Empowered by Tyler Technologies
Refine Results

The population density of North Amityville, NY was 7,993 in 2018. The population density of Central Falls, RI was 16,177 in 2018.

Population Density

Population Density is computed by dividing the total population by Land Area Per Square Mile.

Above charts are based on data from the U.S. Census American Community Survey | ODN Dataset | API - Notes:

1. ODN datasets and APIs are subject to change and may differ in format from the original source data in order to provide a user-friendly experience on this site.

2. To build your own apps using this data, see the ODN Dataset and API links.

3. If you use this derived data in an app, we ask that you provide a link somewhere in your applications to the Open Data Network with a citation that states: "Data for this application was provided by the Open Data Network" where "Open Data Network" links to http://opendatanetwork.com. Where an application has a region specific module, we ask that you add an additional line that states: "Data about REGIONX was provided by the Open Data Network." where REGIONX is an HREF with a name for a geographical region like "Seattle, WA" and the link points to this page URL, e.g. http://opendatanetwork.com/region/1600000US5363000/Seattle_WA

Geographic and Population Datasets Involving North Amityville, NY or Central Falls, RI

  • API

    NYCHA Development Data Book

    data.cityofnewyork.us | Last Updated 2024-05-13T15:53:04.000Z

    Contains the main body of the "Development Data Book". The Development Data Book lists all of the Authority's Developments alphabetically and includes information on the development identification numbers, program and construction type, number of apartments and rental rooms, population, number of buildings and stories, street boundaries, and political districts.

  • API

    Short-term Industry Projections

    data.ny.gov | Last Updated 2024-03-06T19:36:11.000Z

    Short-term Industry Projections for a 2 year time horizon are provided for the state and 10 labor market regions to provide individuals and organizations with an industry outlook.

  • API

    Long-term Industry Projections

    data.ny.gov | Last Updated 2023-06-30T17:36:30.000Z

    Long-term Industry Projections for a 10 year time horizon are provided for the state and 10 labor market regions to provide individuals and organizations with an industry outlook.

  • API

    Incidence Of Brain And Central Nervous System Cancer Age 15 Under Per 1,000,000 All States

    opendata.utah.gov | Last Updated 2019-04-19T01:42:51.000Z

    Incidence Of Brain And Central Nervous System Cancer Age 15 Under Per 1,000,000 All States

  • API

    Rates of COVID-19 Cases or Deaths by Age Group and Updated (Bivalent) Booster Status

    data.cdc.gov | Last Updated 2023-06-01T16:51:17.000Z

    Data for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Updated (Bivalent) Booster Status. Click 'More' for important dataset description and footnotes Webpage: https://covid.cdc.gov/covid-data-tracker/#rates-by-vaccine-status Dataset and data visualization details: These data were posted and archived on May 30, 2023 and reflect cases among persons with a positive specimen collection date through April 22, 2023, and deaths among persons with a positive specimen collection date through April 1, 2023. These data will no longer be updated after May 2023. Vaccination status: A person vaccinated with at least a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. A person vaccinated with a primary series and a monovalent booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably receiving a primary series of an FDA-authorized or approved vaccine and at least one additional dose of any monovalent FDA-authorized or approved COVID-19 vaccine on or after August 13, 2021. (Note: this definition does not distinguish between vaccine recipients who are immunocompromised and are receiving an additional dose versus those who are not immunocompromised and receiving a booster dose.) A person vaccinated with a primary series and an updated (bivalent) booster dose had SARS-CoV-2 RNA or antigen detected in a respiratory specimen collected ≥14 days after verifiably receiving a primary series of an FDA-authorized or approved vaccine and an additional dose of any bivalent FDA-authorized or approved vaccine COVID-19 vaccine on or after September 1, 2022. (Note: Doses with bivalent doses reported as first or second doses are classified as vaccinated with a bivalent booster dose.) People with primary series or a monovalent booster dose were combined in the “vaccinated without an updated booster” category. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Per the interim guidance of the Council of State and Territorial Epidemiologists (CSTE), this should include persons whose death certificate lists COVID-19 disease or SARS-CoV-2 as the underlying cause of death or as a significant condition contributing to death. Rates of COVID-19 deaths by vaccination status are primarily reported based on when the patient was tested for COVID-19. In select jurisdictions, deaths are included that are not laboratory confirmed and are reported based on alternative dates (i.e., onset date for most; or date of death or report date, where onset date is unavailable). Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 24 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Colorado, District of Columbia, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (NY), North Carolina, Rhode Island, Tennessee, Texas, Utah, and West Virginia; 23 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 48% of the total U.S. population and all ten of the Health and Human Services Regions. This list will be

  • API

    RSBS SMO: Part 1 of 2, New York State Residential Statewide Baseline Study: Single and Multifamily Occupant Telephone or Web Survey

    data.ny.gov | Last Updated 2019-11-15T21:47:19.000Z

    How does your organization use this dataset? What other NYSERDA or energy-related datasets would you like to see on Open NY? Let us know by emailing OpenNY@nyserda.ny.gov. This is part 1 (contains: Behavior and Demographics; Building Shell; Kitchen Appliances; and Heating and Cooling) of 2; part 2 (https://data.ny.gov/d/87mp-9bnv) contains: Clothes Washing and Drying; Water Heating; Home Lighting; Pool and Spa; Small Household Appliances; and Miscellaneous Equipment. The New York State Energy Research and Development Authority (NYSERDA), in collaboration with the New York State Department of Public Service (DPS), conducted a statewide residential baseline study (study) from 2011 to 2014 of the single-family and multifamily residential housing segments, including new construction, and a broad range of energy uses and efficiency measures. This dataset includes 2,982 single-family and 379 multifamily occupant survey completes for a total of 3,361 responses. The survey involved 2,285 Web, 1,041 telephone, and 35 mini-inspection surveys. The survey collected information on the following building characteristics: building shell, kitchen appliances, heating and cooling equipment, water heating equipment, clothes washing and drying equipment, lighting, pool and spa equipment, small household appliances, miscellaneous energy consuming equipment, as well as behaviors and characteristics of respondents.

  • API

    RSBS: Single Family On-Site Inspections, Measure Level, New York State Residential Statewide Baseline Study

    data.ny.gov | Last Updated 2019-11-15T21:48:02.000Z

    How does your organization use this dataset? What other NYSERDA or energy-related datasets would you like to see on Open NY? Let us know by emailing OpenNY@nyserda.ny.gov. The New York State Energy Research and Development Authority (NYSERDA), in collaboration with the New York State Department of Public Service (DPS), conducted a statewide residential baseline study (study) from 2011 to 2014 of the single-family and multifamily residential housing segments, including new construction, and a broad range of energy uses and efficiency measures. This dataset includes data collected from a total of 700 on-site inspections of single family buildings. The types of data collected during the inspections covers property characteristics, heating and cooling equipment, water heating equipment, appliances, lighting, clothes washing and drying, miscellaneous energy using equipment, and observable operating behavior. The objective of the inspections was to enhance the residential baseline study with detailed on-site information and, to the degree possible, verify self-reported data from the phone and web surveys.